Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

16.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

18.9K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.9K
Genetic Screens02:46

Genetic Screens

5.8K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

59
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
59
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

18.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tacrolimus Levels 10 Years After Kidney Transplant and Long-Term Clinical Outcomes: A Propensity Score-Matched Analysis.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same author

Diagnostic Accuracy of Extracellular versus Hepatobiliary Contrast-enhanced MRI in LI-RADS Nonradiation Treatment Response Algorithm Version 2024.

Radiology·2026
Same author

Integrative genomic analysis of 21 orofacial diseases identifies shared genetic architecture with systemic diseases.

Nature communications·2026
Same author

Intratumoral PKM2 expression predicts benefit from adjuvant FOLFOX in stage II-III colorectal cancer.

Journal of gastrointestinal oncology·2026
Same author

Coronary angiography/revascularization status and 1-year cardiovascular outcomes in survivors of out-of-hospital cardiac arrest.

Scientific reports·2026
Same author

Discovery of gene-alcohol interaction loci influencing blood pressure in 1.1 million individuals from multiple populations.

Research square·2026
Same journal

Applying Bayesian Multivariable Mendelian Randomisation to Prioritise Candidate Causal Traits From High-Dimensional Data: Illustration From Estimation of the Effect of Maternal Metabolites on Offspring Birthweight.

Genetic epidemiology·2026
Same journal

Individualized Bayesian Inference Identifies Novel Genetic Variants for Parkinson's Disease.

Genetic epidemiology·2026
Same journal

DRIVE v3: Command Line Application for Identity-by-Descent Haplotype Clustering in Large Biobank Scale Data.

Genetic epidemiology·2026
Same journal

Deep Unsupervised Domain Adaptation for Translating Cancer Dependency Maps From Cell Lines to Breast Cancer Tumor Genomics.

Genetic epidemiology·2026
Same journal

Polygenic Risk Scores for Incident Dementia in the Multi-Ethnic Study of Atherosclerosis.

Genetic epidemiology·2026
Same journal

Outcome and Exposure Polygenic Risk Scores Can Help Reduce Information Bias and Selection Bias in Regression Estimates From Biobank Data.

Genetic epidemiology·2026
See all related articles

Related Experiment Video

Updated: Feb 27, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.5K

Improving power for rare-variant tests by integrating external controls.

Seunggeun Lee1,2, Sehee Kim1, Christian Fuchsberger1,2,3

  • 1Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.

Genetic Epidemiology
|June 29, 2017
PubMed
Summary
This summary is machine-generated.

Integrating external controls into rare-variant tests boosts statistical power. Novel methods control for batch effects, improving accuracy in genomic studies, especially for complex diseases.

Keywords:
Rare-variant testexternal controlsnext-generation sequencing

More Related Videos

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

15.8K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.6K

Related Experiment Videos

Last Updated: Feb 27, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.5K
Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

15.8K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.6K

Area of Science:

  • Genomics and Bioinformatics
  • Statistical Genetics
  • Computational Biology

Background:

  • Decreasing sequencing costs are rapidly increasing the number of available sequenced genomes.
  • External control samples offer potential to enhance the power of rare-variant association tests.
  • Batch effects from diverse sequencing platforms and analysis pipelines can inflate type I error rates when using external controls.

Purpose of the Study:

  • To develop novel statistical methods for integrating external control samples into rare-variant tests.
  • To control for type I error rates introduced by batch effects when using external controls.
  • To improve the power of single, gene-based, and region-based rare-variant tests.

Main Methods:

  • Proposed novel summary statistics-based rare-variant tests.
  • Developed an approach to assess batch effects by comparing odds ratio estimates from internal versus combined internal and external controls.
  • Implemented methods for single, gene-based, and region-based analyses.

Main Results:

  • The proposed methods effectively control for type I error rates when integrating external controls.
  • The novel approach demonstrated a substantial improvement in statistical power.
  • Validated through simulation experiments and analyses of age-related macular degeneration and type 2 diabetes datasets.

Conclusions:

  • Novel summary statistics-based tests allow effective integration of external controls in rare-variant analyses.
  • The methods successfully control for type I error, mitigating batch effect inflation.
  • This approach offers a powerful strategy for increasing the discovery potential of rare genetic variants in large-scale genomic studies.